Correction to: Scientific Reports https://doi.org/10.1038/s41598-023-50378-9, published online 03 January 2024

The original version of this Article contained an error in Reference 45, which was incorrectly given as:

Frencesco, J. R. et al. Neutrophil-to-lymphocyte ratio is a major prognostic factor in non-small cell lung carcinoma patients undergoing first line immunotherapy with pembrolizumab. Cancer Diagn. Progn. 3, 44–52 (2023).

The correct reference is listed below:

Romano, F. J. et al. Neutrophil-to-lymphocyte ratio is a major prognostic factor in non-small cell lung carcinoma patients undergoing first line immunotherapy with pembrolizumab. Cancer Diagn. Progn. 3(1), 44–52. https://doi.org/10.21873/cdp.10178 (2023).

The original Article has been corrected.